Verition Fund Management LLC
Institutional investor · Portfolio as of Q2 2019
Top Holdings1,033 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
ARKO Petroleum Corp. | 2.6M | $184M | 5.2% | — | — | — | New — |
BANK OF NOVA SCOTIA | 3M | $163.1M | 4.6% | — | — | — | Increased — |
ALTABA INC | 2.3M | $156.6M | 4.4% | — | — | — | New — |
TC ENERGY CORP | 3M | $148.6M | 4.2% | — | — | — | New — |
CAN IMPERIAL BK OF COMMERCE | 1.5M | $117.8M | 3.3% | — | — | — | New — |
VODAFONE GROUP PLC-SP ADR | 6.5M | $105.6M | 3.0% | $11.17 | -6.44% | 3 qtrssince 2018-Q4 | Increased 61 |
ALTABA INC | 1.2M | $86.6M | 2.4% | — | — | 1 qtr | New 77 |
ALLERGAN PLC | 369,800 | $61.9M | 1.7% | — | — | — | New — |
ALTABA INC | 830,100 | $57.6M | 1.6% | — | — | — | New — |
CELGENE CORP | 591,000 | $54.6M | 1.5% | — | — | — | New — |
WELLCARE HEALTH PLANS INC | 181,300 | $51.7M | 1.5% | — | — | — | New — |
CENTENE CORP | 947,900 | $49.7M | 1.4% | — | — | — | New — |
ARKO Petroleum Corp. | 647,900 | $45.7M | 1.3% | — | — | — | New — |
| 20.8M | $43.5M | 1.2% | — | — | 3 qtrssince 2018-Q4 | Decreased 0 | |
BP PLC-SPONS ADR | 976,037 | $40.7M | 1.1% | $28.17 | -0.36% | 2 qtrssince 2019-Q1 | Increased 74 |
ABBVIE INC | 553,200 | $40.2M | 1.1% | — | — | — | New — |
WELLCARE HEALTH PLANS INC | 128,700 | $36.7M | 1.0% | — | — | — | New — |
| 29.9M | $35.4M | 1.0% | — | — | 3 qtrssince 2018-Q4 | Increased 52 | |
| 18.3M | $33.2M | 0.9% | — | — | — | Decreased 0 | |
| 21.9M | $33.2M | 0.9% | — | — | — | Increased 41 |
Verition Fund Management LLC manages $3.6B across 1033 positions as of Q2 2019. Top holdings: APC (5.2%), BNS (4.6%), AABA (4.4%). Fund DNA: Balanced Allocator. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 436 new positions, 490 exits, 218 increased. Top move: AABA (NEW, conviction 77). Portfolio: $3.6B across 1033 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer